Think Research Corp (TSXV:THNK)
C$ 0.315 0 (0%) Market Cap: 24.82 Mil Enterprise Value: 71.97 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 18/100

Think Research Corporation at Bloom Burton & Co. Healthcare Investor Conference Transcript

May 03, 2022 / 06:30PM GMT
Release Date Price: C$0.79 (-1.25%)
Unidentified Participant

Next presenting company is Think Research. It is being presented by Sachin Aggarwal, CEO.

Sachin Aggarwal
Think Research Corporation - CEO

All right. Can you hear me clearly? Yes. Excellent.

Thank you for joining us today. Think Research, we are a relatively young public company; about 16 months now on the Toronto Venture Exchange. Pleased to be here. I think it's our fifth year here at Bloom Burton and our second as a public company. So, for -- I do see some familiar faces in the crowd, so appreciate you coming to join us again. For those of you for whom we are new, let me just give you a little bit of background on what we are and who we are and what we do.

So, we are a software company. And what we do is we get the latest in clinical evidence and clinical knowledge into the hands of doctors, nurses, and pharmacists. That's new evidence and new best practice out to the point of care so that those care providers practice better care.

We are -- our mission is to organize the world's health knowledge so everyone gets

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot